|
Market Closed -
Nasdaq
06:00:00 12/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 781.49 USD | -1.48% |
|
-5.59% | +1.25% |
| Market Cap | 79.21B 68.25B 64.62B 58.57B 110B 7,567B 110B 768B 295B 3,850B 297B 291B 12,166B | P/E 2026 * |
18.4x | P/E 2027 * | 15.7x |
|---|---|---|---|---|---|
| Enterprise Value | 72.04B 62.07B 58.77B 53.27B 99.94B 6,882B 100B 698B 268B 3,501B 271B 265B 11,064B | EV / Sales 2026 * |
4.26x | EV / Sales 2027 * | 3.74x |
| Free-Float |
71.06% | Yield 2026 * |
0.49% | Yield 2027 * | 0.55% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Xetra
| RGO | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -1.48% | ||
| 1 week | -5.59% | ||
| Current month | -2.20% | ||
| 1 month | -1.95% | ||
| 3 months | +27.80% | ||
| 6 months | +0.88% | ||
| Current year | +1.25% |
| 1 week | 780.81 |  | 821.17 |
| 1 month | 779.08 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | -5.59% | +37.54% | -6.24% | 79.21B | |
| -1.42% | -4.79% | -20.78% | -38.31% | 58.22B | |
| +5.38% | -1.09% | +467.03% | +36.08% | 54.54B | |
| -0.56% | -4.20% | -11.00% | +27.11% | 48.89B | |
| +1.93% | -6.84% | -1.34% | +149.15% | 44.72B | |
| +0.80% | -1.67% | +45.89% | -16.13% | 31.83B | |
| -1.47% | -4.17% | +40.97% | +88.59% | 24.99B | |
| -0.85% | -8.82% | -6.07% | +164.64% | 20.95B | |
| -0.09% | -4.70% | +62.73% | +102.03% | 15.8B | |
| -0.08% | -3.21% | +37.72% | +153.91% | 14.17B | |
| Average | +0.26% | -5.17% | +65.27% | +66.08% | 39.33B | |
| Weighted average by Cap. | +0.37% | -5.33% | +77.60% | +41.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.93B 14.58B 13.81B 12.52B 23.48B 1,617B 23.6B 164B 63.07B 823B 63.57B 62.17B 2,600B | 18.48B 15.93B 15.08B 13.67B 25.64B 1,766B 25.77B 179B 68.87B 898B 69.42B 67.89B 2,839B |
| Net income | 4.77B 4.11B 3.89B 3.53B 6.62B 456B 6.66B 46.25B 17.79B 232B 17.93B 17.53B 733B | 5.45B 4.69B 4.44B 4.03B 7.55B 520B 7.59B 52.76B 20.29B 265B 20.45B 20B 836B |
| Net Debt | -7.17B -6.18B -5.85B -5.3B -9.95B -685B -10B -69.49B -26.72B -349B -26.93B -26.34B -1,101B | -10.05B -8.66B -8.2B -7.44B -13.95B -961B -14.02B -97.43B -37.46B -489B -37.76B -36.93B -1,544B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/09/26 | USD 781.49 | -1.48% | 439,210 |
| 10/09/26 | USD 793.26 | -1.78% | 526,911 |
| 09/09/26 | USD 807.65 | -0.33% | 621,458 |
| 08/09/26 | USD 810.31 | -2.10% | 556,536 |
| 04/09/26 | USD 827.72 | -1.87% | 561,170 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
